Medicare Enrolled
Dr. Rajesh Ramineni, MD
Advanced Heart Failure and Transplant Cardiology Physician · Conroe, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ramineni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramineni? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ramineni
Dr. Rajesh Ramineni is an advanced heart failure and transplant cardiology physician in Conroe, TX, with 18 years in practice. Based on federal Medicare data, Dr. Ramineni performed 3,130 Medicare services across 2,246 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ramineni received a total of $35,078 from 60 pharmaceutical and/or device companies across 790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in advanced heart failure and transplant cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramineni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 3% volume in TX$ $35,078 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,130
Medicare services
Top 3% in TX for advanced heart failure and transplant cardiology physician
2,246
Unique beneficiaries
$155
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~174 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 628 | $90 | $323 |
| Regadenoson injection (Lexiscan) for heart stress test | 458 | $40 | $151 |
| Electrocardiogram (EKG), 12-lead | 397 | $10 | $50 |
| Echocardiogram, transthoracic | 197 | $144 | $668 |
| New patient office visit (45-59 min) | 110 | $122 | $481 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 107 | $535 | $1,523 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 99 | $30 | $118 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 94 | $1,799 | $7,415 |
| Nuclear medicine study of heart muscle blood flow by pet | 92 | $135 | $598 |
| Remote patient monitoring device, 30 days | 83 | $37 | $159 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 82 | $14 | $54 |
| Remote patient monitoring management, 20 min/month | 80 | $36 | $145 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 78 | $139 | $585 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 59 | $10 | $132 |
| Initial hospital admission, high complexity | 58 | $139 | $480 |
| Initial hospital admission, moderate complexity | 57 | $100 | $419 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 51 | $19 | $77 |
| Office visit, established patient, complex (40-54 min) | 51 | $132 | $438 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 46 | $632 | $2,064 |
| Cardiac catheterization | 40 | $179 | $1,394 |
| Hospital follow-up visit, moderate complexity | 40 | $63 | $204 |
| Office visit, established patient (20-29 min) | 30 | $67 | $205 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 29 | $821 | $3,828 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 28 | $88 | $344 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 25 | $16 | $80 |
| Ultrasonic guidance for blood vessel access | 23 | $11 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $48 | $174 |
| Coronary stent placement | 18 | $444 | $1,684 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $320 | $1,097 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | $83 | $332 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 16 | $21 | $311 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.1% high complexity
26.1% medium
65.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,078
Total received (2018-2024)
Avg $5,011/year across 7 years
Top 15% in TX for advanced heart failure and transplant cardiology physician
60
Companies
790
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,238 (86.2%)
Other
Charitable contributions, space rental, and other categories
$3,974 (11.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$832 (2.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$34 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$7,899
2023$4,735
2022$4,245
2021$6,125
2020$3,841
2019$4,352
2018$3,881
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$7,705
AngioDynamics, Inc.
$4,231
Medtronic, Inc.
$2,393
Novartis Pharmaceuticals Corporation
$2,182
Medtronic Vascular, Inc.
$2,160
BIOTRONIK INC.
$2,009
ATRICURE, INC.
$1,654
Amgen Inc.
$1,437
Philips Electronics North America Corporation
$1,252
Boston Scientific Corporation
$1,108
Impulse Dynamics (USA) Inc.
$963
Inari Medical, Inc.
$746
Janssen Pharmaceuticals, Inc
$718
E.R. Squibb & Sons, L.L.C.
$521
Esperion Therapeutics, Inc.
$463
Boehringer Ingelheim Pharmaceuticals, Inc.
$450
AstraZeneca Pharmaceuticals LP
$402
ABIOMED
$386
Actelion Pharmaceuticals US, Inc.
$379
Penumbra, Inc.
$288
PFIZER INC.
$262
Chiesi USA, Inc.
$262
CARDIVA MEDICAL, INC.
$246
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$200
Lexicon Pharmaceuticals, Inc.
$190
Venclose Inc.
$162
BOSTON SCIENTIFIC CORPORATION
$162
Cardiovascular Systems Inc.
$161
SANOFI-AVENTIS U.S. LLC
$158
Tactile Systems Technology Inc
$157
CHIESI USA, INC.
$149
Regeneron Healthcare Solutions, Inc.
$142
GE HEALTHCARE
$120
Bayer HealthCare Pharmaceuticals Inc.
$112
Baxter Healthcare
$112
Cook Medical LLC
$111
HeartFlow, Inc.
$106
Kestra Medical Technology Services, Inc.
$98
Merck Sharp & Dohme LLC
$96
CVRx, Inc.
$82
Biosense Webster, Inc.
$79
Kiniksa Pharmaceuticals, Ltd.
$53
Astellas Pharma US Inc
$42
Edwards Lifesciences Corporation
$37
ARBOR PHARMACEUTICALS, INC.
$37
Siemens Medical Solutions USA, Inc.
$35
Kowa Pharmaceuticals America, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Inspire Medical Systems, Inc.
$24
Lantheus Medical Imaging, Inc.
$22
ARALEZ PHARMACEUTICALS US INC.
$20
ZOLL Circulation Inc
$19
Lilly USA, LLC
$16
Avinger Inc.
$16
Braemar Manufacturing, LLC
$14
Allergan Inc.
$14
CashFlow Solutions, LLC
$11
Amarin Pharma Inc.
$11
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 40.8% of total payments
Associated products mentioned in payments ›
(5139) IGT Fixed SV TnM · (6554) Periph Vasc Undiv · (9520) IGT Devices Undivided · AMPLATZER AMULET · AMPLATZER TALISMAN · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AZURE XT DR MRI SURESCAN · Abre · Acticor 7 VR-T DX · Adempas · Agilis NxT EP Introducer · Allia · Allure CRT Pacemaker · Arcalyst · Assure WCD · Assurity Pacemaker · Auryon Laser System 100-120 Vac · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor · BodyGuardian · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · CorPath GRX · CoreValve Evolut · Corlanor · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Definity · Diamondback Peripheral · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · ESPRIT · EVRSF · Edarbyclor · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · FLOWTRIEVER CATHETER · Flexitouch Plus · GALLANT · GENERAL - THROMBECTOMY · GENERAL - VASCULAR INTERVENTION · HeartMate 3 Left Ventricular Assist Device · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · IN.PACT Admiral · INSPIRE · INTELLIS ADAPTIVESTIM · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · Livalo · MERLIN@HOME · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Optimizer Smart System · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Pacemakers · Pacing Leads · QUADRA ASSURA · QUARTET · Quadra Allure MP RF CRT Pacemkr · RESONATE · Repatha · Rivacor 7 DR-T · S · SAVVYWIRE · SYMPLICITY G3 · SYNERGY ABLATION SYSTEM · Sentinel · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRULICITY · Temperature Management System · UPTRAVI · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Closure Device · VenaSeal · Verquvo · ViewFlex Xtra ICE Catheter · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZILVER PTX · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1,121 per 100 Medicare services performed
Geographic Context
Advanced Heart Failure and Transplant Cardiology Physicians within 10 mi
2
Per 100K population
0.3
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ramineni is a clinical cardiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 15%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ramineni experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ramineni performed 628 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ramineni receive payments from pharmaceutical companies?
Yes. Dr. Ramineni received a total of $35,078 from 60 companies across 790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramineni's costs compare to other advanced heart failure and transplant cardiology physicians in Conroe?
Dr. Ramineni's average Medicare payment per service is $155. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramineni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Advanced Heart Failure and Transplant Cardiology Physicians in Conroe
Browse advanced heart failure and transplant cardiology physicians in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Advanced Heart Failure and Transplant Cardiology Physicians in TX
Advanced Heart Failure and Transplant Cardiology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Advanced Heart Failure and Transplant Cardiology Physicians in TX
Which TX advanced heart failure and transplant cardiology physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology